Patent holdings for IPC class C12N 9/64

Total number of patents in this class: 2220

10-year publication summary

149
183
202
210
209
214
213
172
144
56
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Immatics Biotechnologies GmbH
1144
91
Takeda Pharmaceutical Company Limited
2961
52
Bioverativ Therapeutics Inc.
220
48
Regeneron Pharmaceuticals, Inc.
3650
46
Modernatx, Inc.
1181
39
Chr. Hansen A/S
979
35
Alexion Pharmaceuticals, Inc.
606
30
The Children's Hospital of Philadelphia
716
23
The Trustees of the University of Pennsylvania
4122
22
Laboratoire Francais du Fractionnement et des Biotechnologies
306
20
Novo Nordisk Health Care AG
342
20
Vertex Pharmaceuticals Incorporated
1581
18
Translate bio, Inc.
394
17
F. Hoffmann-La Roche AG
7958
16
Opko Biologics Ltd.
75
16
Novozymes A/S
3314
15
Octapharma AG
201
14
Research Development Foundation
234
14
The Regents of the University of California
18943
13
Genentech, Inc.
3742
13
Other owners 1658